The global market for DPP-4 Inhibitor Innovative Drugs was valued at US$ 305 million in the year 2024 and is projected to reach a revised size of US$ 459 million by 2031, growing at a CAGR of 6.1% during the forecast period.

DPP-4 Inhibitor Innovative Drugs Market

Dipeptidyl Peptidase-4 (DPP-4) inhibitor innovative drugs are a class of advanced therapeutics for type 2 diabetes management. By inhibiting the DPP-4 enzyme, these drugs enhance the activity of incretin hormones, promoting insulin secretion while reducing glucagon levels, thus improving blood glucose control. Compared to traditional diabetes treatments, innovative DPP-4 inhibitors offer enhanced efficacy, improved safety profiles, and potential benefits such as cardiovascular and renal protection. They represent a significant advancement in diabetes therapy, providing patients with more effective and convenient treatment options.

North American market for DPP-4 Inhibitor Innovative Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for DPP-4 Inhibitor Innovative Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of DPP-4 Inhibitor Innovative Drugs include Merck & Co, Novartis, AstraZeneca, Eli Lilly, Hengrui, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, Haisco Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DPP-4 Inhibitor Innovative Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPP-4 Inhibitor Innovative Drugs.

The DPP-4 Inhibitor Innovative Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DPP-4 Inhibitor Innovative Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the DPP-4 Inhibitor Innovative Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DPP-4 Inhibitor Innovative Drugs Market Report

Report Metric	Details
Report Name	DPP-4 Inhibitor Innovative Drugs Market
Accounted market size in year	US$ 305 million
Forecasted market size in 2031	US$ 459 million
CAGR	6.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Weekly Biweekly
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co, Novartis, AstraZeneca, Eli Lilly, Hengrui, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, Haisco Pharmaceutical, Easton Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPP-4 Inhibitor Innovative Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPP-4 Inhibitor Innovative Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is DPP-4 Inhibitor Innovative Drugs Market growing?

Ans: The DPP-4 Inhibitor Innovative Drugs Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the DPP-4 Inhibitor Innovative Drugs Market size in 2031?

Ans: The DPP-4 Inhibitor Innovative Drugs Market size in 2031 will be US$ 459 million.

Who are the main players in the DPP-4 Inhibitor Innovative Drugs Market report?

Ans: The main players in the DPP-4 Inhibitor Innovative Drugs Market are Merck & Co, Novartis, AstraZeneca, Eli Lilly, Hengrui, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, Haisco Pharmaceutical, Easton Biopharmaceuticals

What are the Application segmentation covered in the DPP-4 Inhibitor Innovative Drugs Market report?

Ans: The Applications covered in the DPP-4 Inhibitor Innovative Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the DPP-4 Inhibitor Innovative Drugs Market report?

Ans: The Types covered in the DPP-4 Inhibitor Innovative Drugs Market report are Weekly, Biweekly

1 DPP-4 Inhibitor Innovative Drugs Market Overview

1.1 Product Definition

1.2 DPP-4 Inhibitor Innovative Drugs by Type

1.2.1 Global DPP-4 Inhibitor Innovative Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Weekly

1.2.3 Biweekly

1.3 DPP-4 Inhibitor Innovative Drugs by Application

1.3.1 Global DPP-4 Inhibitor Innovative Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global DPP-4 Inhibitor Innovative Drugs Market Size Estimates and Forecasts

1.4.1 Global DPP-4 Inhibitor Innovative Drugs Revenue 2020-2031

1.4.2 Global DPP-4 Inhibitor Innovative Drugs Sales 2020-2031

1.4.3 Global DPP-4 Inhibitor Innovative Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 DPP-4 Inhibitor Innovative Drugs Market Competition by Manufacturers

2.1 Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global DPP-4 Inhibitor Innovative Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of DPP-4 Inhibitor Innovative Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of DPP-4 Inhibitor Innovative Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of DPP-4 Inhibitor Innovative Drugs, Product Type & Application

2.7 Global Key Manufacturers of DPP-4 Inhibitor Innovative Drugs, Date of Enter into This Industry

2.8 Global DPP-4 Inhibitor Innovative Drugs Market Competitive Situation and Trends

2.8.1 Global DPP-4 Inhibitor Innovative Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest DPP-4 Inhibitor Innovative Drugs Players Market Share by Revenue

2.8.3 Global DPP-4 Inhibitor Innovative Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global DPP-4 Inhibitor Innovative Drugs Market Scenario by Region

3.1 Global DPP-4 Inhibitor Innovative Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global DPP-4 Inhibitor Innovative Drugs Sales by Region: 2020-2031

3.2.1 Global DPP-4 Inhibitor Innovative Drugs Sales by Region: 2020-2025

3.2.2 Global DPP-4 Inhibitor Innovative Drugs Sales by Region: 2026-2031

3.3 Global DPP-4 Inhibitor Innovative Drugs Revenue by Region: 2020-2031

3.3.1 Global DPP-4 Inhibitor Innovative Drugs Revenue by Region: 2020-2025

3.3.2 Global DPP-4 Inhibitor Innovative Drugs Revenue by Region: 2026-2031

3.4 North America DPP-4 Inhibitor Innovative Drugs Market Facts & Figures by Country

3.4.1 North America DPP-4 Inhibitor Innovative Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2031)

3.4.3 North America DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe DPP-4 Inhibitor Innovative Drugs Market Facts & Figures by Country

3.5.1 Europe DPP-4 Inhibitor Innovative Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2031)

3.5.3 Europe DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific DPP-4 Inhibitor Innovative Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific DPP-4 Inhibitor Innovative Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific DPP-4 Inhibitor Innovative Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific DPP-4 Inhibitor Innovative Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America DPP-4 Inhibitor Innovative Drugs Market Facts & Figures by Country

3.7.1 Latin America DPP-4 Inhibitor Innovative Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2031)

3.7.3 Latin America DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa DPP-4 Inhibitor Innovative Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa DPP-4 Inhibitor Innovative Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global DPP-4 Inhibitor Innovative Drugs Sales by Type (2020-2031)

4.1.1 Global DPP-4 Inhibitor Innovative Drugs Sales by Type (2020-2025)

4.1.2 Global DPP-4 Inhibitor Innovative Drugs Sales by Type (2026-2031)

4.1.3 Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Type (2020-2031)

4.2 Global DPP-4 Inhibitor Innovative Drugs Revenue by Type (2020-2031)

4.2.1 Global DPP-4 Inhibitor Innovative Drugs Revenue by Type (2020-2025)

4.2.2 Global DPP-4 Inhibitor Innovative Drugs Revenue by Type (2026-2031)

4.2.3 Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Type (2020-2031)

4.3 Global DPP-4 Inhibitor Innovative Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global DPP-4 Inhibitor Innovative Drugs Sales by Application (2020-2031)

5.1.1 Global DPP-4 Inhibitor Innovative Drugs Sales by Application (2020-2025)

5.1.2 Global DPP-4 Inhibitor Innovative Drugs Sales by Application (2026-2031)

5.1.3 Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Application (2020-2031)

5.2 Global DPP-4 Inhibitor Innovative Drugs Revenue by Application (2020-2031)

5.2.1 Global DPP-4 Inhibitor Innovative Drugs Revenue by Application (2020-2025)

5.2.2 Global DPP-4 Inhibitor Innovative Drugs Revenue by Application (2026-2031)

5.2.3 Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Application (2020-2031)

5.3 Global DPP-4 Inhibitor Innovative Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck & Co

6.1.1 Merck & Co Company Information

6.1.2 Merck & Co Description and Business Overview

6.1.3 Merck & Co DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck & Co DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.1.5 Merck & Co Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Eli Lilly

6.4.1 Eli Lilly Company Information

6.4.2 Eli Lilly Description and Business Overview

6.4.3 Eli Lilly DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eli Lilly DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.4.5 Eli Lilly Recent Developments/Updates

6.5 Hengrui

6.5.1 Hengrui Company Information

6.5.2 Hengrui Description and Business Overview

6.5.3 Hengrui DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hengrui DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.5.5 Hengrui Recent Developments/Updates

6.6 Takeda Pharmaceutical

6.6.1 Takeda Pharmaceutical Company Information

6.6.2 Takeda Pharmaceutical Description and Business Overview

6.6.3 Takeda Pharmaceutical DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Takeda Pharmaceutical DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.6.5 Takeda Pharmaceutical Recent Developments/Updates

6.7 Furiex

6.7.1 Furiex Company Information

6.7.2 Furiex Description and Business Overview

6.7.3 Furiex DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Furiex DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.7.5 Furiex Recent Developments/Updates

6.8 Beacon Pharma

6.8.1 Beacon Pharma Company Information

6.8.2 Beacon Pharma Description and Business Overview

6.8.3 Beacon Pharma DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beacon Pharma DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.8.5 Beacon Pharma Recent Developments/Updates

6.9 Kelun Pharmaceutical

6.9.1 Kelun Pharmaceutical Company Information

6.9.2 Kelun Pharmaceutical Description and Business Overview

6.9.3 Kelun Pharmaceutical DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Kelun Pharmaceutical DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.9.5 Kelun Pharmaceutical Recent Developments/Updates

6.10 Haisco Pharmaceutical

6.10.1 Haisco Pharmaceutical Company Information

6.10.2 Haisco Pharmaceutical Description and Business Overview

6.10.3 Haisco Pharmaceutical DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Haisco Pharmaceutical DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.10.5 Haisco Pharmaceutical Recent Developments/Updates

6.11 Easton Biopharmaceuticals

6.11.1 Easton Biopharmaceuticals Company Information

6.11.2 Easton Biopharmaceuticals Description and Business Overview

6.11.3 Easton Biopharmaceuticals DPP-4 Inhibitor Innovative Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Easton Biopharmaceuticals DPP-4 Inhibitor Innovative Drugs Product Portfolio

6.11.5 Easton Biopharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 DPP-4 Inhibitor Innovative Drugs Industry Chain Analysis

7.2 DPP-4 Inhibitor Innovative Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 DPP-4 Inhibitor Innovative Drugs Production Mode & Process Analysis

7.4 DPP-4 Inhibitor Innovative Drugs Sales and Marketing

7.4.1 DPP-4 Inhibitor Innovative Drugs Sales Channels

7.4.2 DPP-4 Inhibitor Innovative Drugs Distributors

7.5 DPP-4 Inhibitor Innovative Drugs Customer Analysis

8 DPP-4 Inhibitor Innovative Drugs Market Dynamics

8.1 DPP-4 Inhibitor Innovative Drugs Industry Trends

8.2 DPP-4 Inhibitor Innovative Drugs Market Drivers

8.3 DPP-4 Inhibitor Innovative Drugs Market Challenges

8.4 DPP-4 Inhibitor Innovative Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

Furiex

Beacon Pharma

Kelun Pharmaceutical

Haisco Pharmaceutical

Easton Biopharmaceuticals

List of Tables

Table 1. Global DPP-4 Inhibitor Innovative Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global DPP-4 Inhibitor Innovative Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global DPP-4 Inhibitor Innovative Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global DPP-4 Inhibitor Innovative Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global DPP-4 Inhibitor Innovative Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global DPP-4 Inhibitor Innovative Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market DPP-4 Inhibitor Innovative Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of DPP-4 Inhibitor Innovative Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of DPP-4 Inhibitor Innovative Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of DPP-4 Inhibitor Innovative Drugs, Product Type & Application

Table 12. Global Key Manufacturers of DPP-4 Inhibitor Innovative Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global DPP-4 Inhibitor Innovative Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPP-4 Inhibitor Innovative Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global DPP-4 Inhibitor Innovative Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global DPP-4 Inhibitor Innovative Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Region (2020-2025)

Table 19. Global DPP-4 Inhibitor Innovative Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Region (2026-2031)

Table 21. Global DPP-4 Inhibitor Innovative Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global DPP-4 Inhibitor Innovative Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America DPP-4 Inhibitor Innovative Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America DPP-4 Inhibitor Innovative Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America DPP-4 Inhibitor Innovative Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe DPP-4 Inhibitor Innovative Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe DPP-4 Inhibitor Innovative Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe DPP-4 Inhibitor Innovative Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific DPP-4 Inhibitor Innovative Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific DPP-4 Inhibitor Innovative Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific DPP-4 Inhibitor Innovative Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific DPP-4 Inhibitor Innovative Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific DPP-4 Inhibitor Innovative Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America DPP-4 Inhibitor Innovative Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America DPP-4 Inhibitor Innovative Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America DPP-4 Inhibitor Innovative Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global DPP-4 Inhibitor Innovative Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global DPP-4 Inhibitor Innovative Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Type (2020-2025)

Table 53. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Type (2026-2031)

Table 54. Global DPP-4 Inhibitor Innovative Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global DPP-4 Inhibitor Innovative Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global DPP-4 Inhibitor Innovative Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global DPP-4 Inhibitor Innovative Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global DPP-4 Inhibitor Innovative Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global DPP-4 Inhibitor Innovative Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Application (2020-2025)

Table 63. Global DPP-4 Inhibitor Innovative Drugs Sales Market Share by Application (2026-2031)

Table 64. Global DPP-4 Inhibitor Innovative Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global DPP-4 Inhibitor Innovative Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global DPP-4 Inhibitor Innovative Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global DPP-4 Inhibitor Innovative Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Merck & Co Company Information

Table 71. Merck & Co Description and Business Overview

Table 72. Merck & Co DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck & Co DPP-4 Inhibitor Innovative Drugs Product

Table 74. Merck & Co Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Novartis DPP-4 Inhibitor Innovative Drugs Product

Table 79. Novartis Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. AstraZeneca DPP-4 Inhibitor Innovative Drugs Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Eli Lilly Company Information

Table 86. Eli Lilly Description and Business Overview

Table 87. Eli Lilly DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Eli Lilly DPP-4 Inhibitor Innovative Drugs Product

Table 89. Eli Lilly Recent Developments/Updates

Table 90. Hengrui Company Information

Table 91. Hengrui Description and Business Overview

Table 92. Hengrui DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Hengrui DPP-4 Inhibitor Innovative Drugs Product

Table 94. Hengrui Recent Developments/Updates

Table 95. Takeda Pharmaceutical Company Information

Table 96. Takeda Pharmaceutical Description and Business Overview

Table 97. Takeda Pharmaceutical DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Takeda Pharmaceutical DPP-4 Inhibitor Innovative Drugs Product

Table 99. Takeda Pharmaceutical Recent Developments/Updates

Table 100. Furiex Company Information

Table 101. Furiex Description and Business Overview

Table 102. Furiex DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Furiex DPP-4 Inhibitor Innovative Drugs Product

Table 104. Furiex Recent Developments/Updates

Table 105. Beacon Pharma Company Information

Table 106. Beacon Pharma Description and Business Overview

Table 107. Beacon Pharma DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Beacon Pharma DPP-4 Inhibitor Innovative Drugs Product

Table 109. Beacon Pharma Recent Developments/Updates

Table 110. Kelun Pharmaceutical Company Information

Table 111. Kelun Pharmaceutical Description and Business Overview

Table 112. Kelun Pharmaceutical DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Kelun Pharmaceutical DPP-4 Inhibitor Innovative Drugs Product

Table 114. Kelun Pharmaceutical Recent Developments/Updates

Table 115. Haisco Pharmaceutical Company Information

Table 116. Haisco Pharmaceutical Description and Business Overview

Table 117. Haisco Pharmaceutical DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Haisco Pharmaceutical DPP-4 Inhibitor Innovative Drugs Product

Table 119. Haisco Pharmaceutical Recent Developments/Updates

Table 120. Easton Biopharmaceuticals Company Information

Table 121. Easton Biopharmaceuticals Description and Business Overview

Table 122. Easton Biopharmaceuticals DPP-4 Inhibitor Innovative Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Easton Biopharmaceuticals DPP-4 Inhibitor Innovative Drugs Product

Table 124. Easton Biopharmaceuticals Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. DPP-4 Inhibitor Innovative Drugs Distributors List

Table 128. DPP-4 Inhibitor Innovative Drugs Customers List

Table 129. DPP-4 Inhibitor Innovative Drugs Market Trends

Table 130. DPP-4 Inhibitor Innovative Drugs Market Drivers

Table 131. DPP-4 Inhibitor Innovative Drugs Market Challenges

Table 132. DPP-4 Inhibitor Innovative Drugs Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of DPP-4 Inhibitor Innovative Drugs

Figure 2. Global DPP-4 Inhibitor Innovative Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global DPP-4 Inhibitor Innovative Drugs Market Share by Type: 2024 & 2031

Figure 4. Weekly Product Picture

Figure 5. Biweekly Product Picture

Figure 6. Global DPP-4 Inhibitor Innovative Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global DPP-4 Inhibitor Innovative Drugs Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global DPP-4 Inhibitor Innovative Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global DPP-4 Inhibitor Innovative Drugs Market Size (2020-2031) & (US$ Million)

Figure 13. Global DPP-4 Inhibitor Innovative Drugs Sales (2020-2031) & (K Units)

Figure 14. Global DPP-4 Inhibitor Innovative Drugs Average Price (US$/Unit) & (2020-2031)

Figure 15. DPP-4 Inhibitor Innovative Drugs Report Years Considered

Figure 16. DPP-4 Inhibitor Innovative Drugs Sales Share by Manufacturers in 2024

Figure 17. Global DPP-4 Inhibitor Innovative Drugs Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest DPP-4 Inhibitor Innovative Drugs Players: Market Share by Revenue in DPP-4 Inhibitor Innovative Drugs in 2024

Figure 19. DPP-4 Inhibitor Innovative Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global DPP-4 Inhibitor Innovative Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America DPP-4 Inhibitor Innovative Drugs Sales Market Share by Country (2020-2031)

Figure 22. North America DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Country (2020-2031)

Figure 23. United States DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe DPP-4 Inhibitor Innovative Drugs Sales Market Share by Country (2020-2031)

Figure 26. Europe DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Country (2020-2031)

Figure 27. Germany DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific DPP-4 Inhibitor Innovative Drugs Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Region (2020-2031)

Figure 34. China DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America DPP-4 Inhibitor Innovative Drugs Sales Market Share by Country (2020-2031)

Figure 42. Latin America DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Country (2020-2031)

Figure 43. Mexico DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa DPP-4 Inhibitor Innovative Drugs Revenue Market Share by Country (2020-2031)

Figure 49. Turkey DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE DPP-4 Inhibitor Innovative Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of DPP-4 Inhibitor Innovative Drugs by Type (2020-2031)

Figure 53. Global Revenue Market Share of DPP-4 Inhibitor Innovative Drugs by Type (2020-2031)

Figure 54. Global DPP-4 Inhibitor Innovative Drugs Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of DPP-4 Inhibitor Innovative Drugs by Application (2020-2031)

Figure 56. Global Revenue Market Share of DPP-4 Inhibitor Innovative Drugs by Application (2020-2031)

Figure 57. Global DPP-4 Inhibitor Innovative Drugs Price (US$/Unit) by Application (2020-2031)

Figure 58. DPP-4 Inhibitor Innovative Drugs Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Dipeptidyl Peptidase IV DPP IV Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dipeptidyl Peptidase 4 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DPP 4 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025

DPP 4 Inhibitor Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tagliptin Market Research Report 2024

Global Diabetes Peptide Drugs Market Research Report 2025

Global Sitagliptin Intermediates Market Research Report 2024

Global Linagliptin Market Research Report 2024

Global Alogliptin Benzoate Reagent Market Research Report 2024

Global Sitagliptin Phosphate API Market Research Report 2025

Global Saxagliptin API Market Research Report 2024

Global Alogliptin Market Research Report 2024

Global Peptide Drugs for Diabetes Market Research Report 2024

Global Synthetic Peptides for Type 2 Diabetes Market Research Report 2024

Global GLP 1 Drug Peptide API Market Research Report 2024

Global Sitagliptin API Market Research Report 2025

Global GLP 1 Receptor Antagonist Market Research Report 2024

GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions